Mitofusin-2 Determines Mitochondrial Network Architecture and Mitochondrial Metabolism
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index; 13 of the 29 sources its claims cite were checked for support.
Abstract
In many cells and specially in muscle, mitochondria form elongated filaments or a branched reticulum. We show that Mfn2 (mitofusin 2), a mitochondrial membrane protein that participates in mitochondrial fusion in mammalian cells, is induced during myogenesis and contributes to the maintenance and operation of the mitochondrial network. Repression of Mfn2 caused morphological and functional fragmentation of the mitochondrial network into independent clusters. Concomitantly, repression of Mfn2 reduced glucose oxidation, mitochondrial membrane potential, cell respiration, and mitochondrial proton leak. We also show that the Mfn2-dependent mechanism of mitochondrial control is disturbed in obesity by reduced Mfn2 expression. In all, our data indicate that Mfn2 expression is crucial in mitochondrial metabolism through the maintenance of the mitochondrial network architecture, and reduced Mfn2 expression may explain some of the metabolic alterations associated with obesity.
Overview
CoChat Summary
TL;DR
Mitofusin-2 (Mfn2), a mitochondrial membrane protein induced during myogenesis, is required to maintain the elongated, intralumenally connected mitochondrial network in muscle cells and to sustain mitochondrial metabolism. Mfn2 expression is reduced in skeletal muscle of obese Zucker rats and obese humans, suggesting its loss contributes to the metabolic alterations of obesity.
Key findings
- Mfn2 mRNA (4.7 kb) is predominant in skeletal muscle and heart, and Mfn2 mRNA and protein are markedly induced during L6E9 myoblast differentiation into myotubes, in parallel with development of an extensive mitochondrial network.
- Antisense repression of Mfn2 in L6E9 myotubes (≈50% reduction in mitochondrial extracts) fragmented the network: 82% of mitochondrial filaments were longer than 5 µm in control cells versus only 22% in antisense cells. Laser microirradiation showed loss of membrane potential spread across the whole network in controls but only a very reduced extension in antisense myotubes.
- Mfn2 repression reduced mitochondrial function: glucose oxidation fell by 30% in myotubes and by 30% (or 70% per the Discussion) in 10T1/2 antisense clones; mitochondrial membrane potential fell by nearly 60%; oxygen consumption fell 30%, with coupled respiration unchanged and proton-leak-linked respiration significantly reduced.
- In obesity, Mfn2 mRNA was 34% lower in Zucker obese rats and 36% lower in obese humans; Mfn2 protein was 39% lower (rats) and 43% lower (humans). Obese rat muscle showed higher mitochondrial density (11.2 ± 0.6 vs 8.2 ± 0.5 organelles/10 µm², p < 0.001), 42% greater total mitochondrial surface area, and 25% lower volume per unit area, consistent with a smaller, fragmented network.
Methods
- Differential screening by PCR-select cDNA subtraction on gastrocnemius muscle from obese (fa/fa) versus lean (fa/+) Zucker rats isolated the 321-bp C31 clone, identified as Mfn2; expression was confirmed by Northern blot, competitive-quantitative RT-PCR, and Western blot with an anti-Mfn2 peptide antibody.
- Human samples: vastus lateralis biopsies from 13 healthy lean volunteers (51 ± 2 years; BMI 23 ± 1 kg/m²; insulin 34 ± 2 pmol/liter) and 9 obese volunteers (46 ± 2 years; BMI 34 ± 1 kg/m²; insulin 62 ± 6 pmol/liter), taken before a 3-h euglycemic hyperinsulinemic clamp (insulin 12 pmol/kg/min); obese subjects showed 50% lower insulin-stimulated glucose disposal (4.9 ± 0.8 vs 10.1 ± 1.1 mg/kg/min).
- Functional work used transient Mfn2 overexpression and antisense knockdown (stable transfection in 10T1/2 fibroblasts; adenoviral antisense in L6E9 myotubes), with confocal immunofluorescence/MitoTracker/JC-1 imaging, laser microirradiation, electron microscopy, [¹⁴C]glucose oxidation, and Clark-electrode respiration measurements; mitochondrial volume/surface area in soleus muscle was quantified by the vertical sections stereological method (4 obese and 4 lean rats, 80 photographs/group at 5,000×).
Limitations
- The paper states that further studies in rodents after recombinant ablation of Mfn2 are required to determine whether it contributes to obesity, and it notes that the mechanism by which Mfn2 supports respiratory chain activity is only postulated (destabilization/reduced activity of certain complexes), not demonstrated.
- The authors note that not all L6E9 myoblasts differentiate in culture (≈30% remain undifferentiated) and that undifferentiated myoblasts are not infected by adenovirus, so the observed reduction in glucose oxidation after antisense infection is a substantial underestimate of the actual inhibition.
- Evident from the text: the human data are cross-sectional and correlational (n = 13 lean, 9 obese), so causality between reduced Mfn2 and obesity-related metabolic alterations is not established; the mitochondrial network/morphology measurements in obesity were made only in Zucker rats, not in human muscle.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
7 Valid · 0 Not valid · 8 Not checked · 69 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We also show that the Mfn2-dependent mechanism of mitochondrial control is disturbed in obesity by reduced Mfn2 expression.”
- Also stated in: § Abstract · plain
“We also show that this regulatory mechanism is disturbed in obesity.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Concomitantly, repression of Mfn2 reduced glucose oxidation, mitochondrial membrane potential, cell respiration, and mitochondrial proton leak.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Concomitantly, repression of Mfn2 reduced glucose oxidation, mitochondrial membrane potential, cell respiration, and mitochondrial proton leak.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“In myoblast cells, a short portion of a mitochondrial filament became de-energized when one of the cluster-composing mitochondria was damaged by laser (Fig. 3,C and D). As a consequence of the loss of mitochondrial membrane potential, mitochondria became unstained by JC-1.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Under these conditions, we found that myogenesis caused the induction of Mfn2 protein in L6E9 cells (Fig. 2C).”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
41 more claims
Create a free account to see all 84 claims and every source verdict.
- Probably not a substantial claim. 15
- It may state two separate claims as one. 27
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Besides its role in mitochondrial fusion, Mfn2 has been described to be involved in the regulation of cell proliferation, oxidative metabolism, autophagy, mitophagy, mitochondrial antiviral signaling, and unfolded protein response (Bach et al, 2003; Chen et al, 2004; Yasukawa et al, 2009; Hailey et al, 2010; Ngoh et al, 2012; Zhao et al, 2012; Chen & Dorn, 2013; Munoz et al, 2013).”
From Mfn2 deficiency links age‐related sarcopenia and impaired autophagy to activation of an adaptive mitophagy pathway (2016) · cites this paper as Bach et al, 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lipid overloading promotes fast and transient changes in mitochondrial architecture.”
From Mitochondrial response to nutrient availability and its role in metabolic disease (2014) · cites this paper as Bach et al, 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In line with the above observations, obese patients display a largely fragmented mitochondrial network in skeletal muscle (Bach et al, 2003).”
From Mitochondrial response to nutrient availability and its role in metabolic disease (2014) · cites this paper as Bach et al, 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mfn2 is a nuclear-encoded mitochondrial protein that shows homology with Drosophila or yeast Fzo proteins (26,27) and is highly expressed in skeletal muscle, the heart, and the brain (23).”
From Expression of Mfn2, the Charcot-Marie-Tooth Neuropathy Type 2A Gene, in Human Skeletal Muscle (2005) · cites this paper as [23]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and mitochondria from obese Zucker rats show higher mitochondrial surface, lower mitochondrial volume, and a lower extent of the mitochondrial network (23).”
From Expression of Mfn2, the Charcot-Marie-Tooth Neuropathy Type 2A Gene, in Human Skeletal Muscle (2005) · cites this paper as [23]
Experimental — accuracy not yet measured
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ RESULTS
“Repression of Mfn2 in 10T1/2 cells also reduced glucose oxidation by 307 (Fig. 8C).”
§ DISCUSSION
“cellular repression of Mfn2 in 10T1/2 cells (687 reduction) reduces mitochondrial proton leak and cellular oxygen consumption (307 reduction) and glucose oxidation (707 reduction)”
Citations
Cites
Maffei, M., Halaas, J., Ravussin, E., Pratley, R. E., Lee, G. H., Zhang, Y., Fei, H., Kim, S., Lallone, R., Ranganathan, S., et al. (1995) · Nature Medicine · doi:10.1038/nm1195-1155 · Cited by 3,725
Dysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321
Delettre, C., Lenaers, G., Griffoin, J.-M., Gigarel, N., Lorenzo, C., Belenguer, P., Pelloquin, L., Grosgeorge, J., Turc-Carel, C., Perret, E., et al. (2000) · Nature Genetics · doi:10.1038/79936 · Cited by 1,446
Alexander, C., Votruba, M., Pesch, U. E. A., Thiselton, D. L., Mayer, S., Moore, A., Rodriguez, M., Kellner, U., Leo-Kottler, B., Auburger, G., et al. (2000) · Nature Genetics · doi:10.1038/79944 · Cited by 1,330
Estimation of surface area from vertical sections
Baddeley, A. J., Gundersen, H. J. G., & Cruz‐Orive, L. M. (1986) · Journal of Microscopy · doi:10.1111/j.1365-2818.1986.tb04282.x · Cited by 1,058
Fuel selection in human skeletal muscle in insulin resistance: a reexamination.
Kelley, D. E., & Mandarino, L. J. (2000) · Diabetes · doi:10.2337/diabetes.49.5.677 · Cited by 1,017
Control of mitochondrial morphology by a human mitofusin
Santel, A., & Fuller, M. T. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.5.867 · Cited by 1,012
Leptin receptor missense mutation in the fatty Zucker rat
Phillips, M. S., Liu, Q., Hammond, H. A., Dugan, V., Hey, P. J., Caskey, C. T., & Hess, J. F. (1996) · Nature Genetics · doi:10.1038/ng0596-18 · Cited by 822
Bett, A. J., Haddara, W., Prevec, L., & Graham, F. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8802 · Cited by 744
A Human Dynamin-related Protein Controls the Distribution of Mitochondria
Smirnova, E., Shurland, D.-L., Ryazantsev, S. N., & van der Bliek, A. M. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.2.351 · Cited by 733
Research works printed but not linked: 3
- Astrup, 1987, Int. J. Obesity, 11, 51
- Kaplan, 1991, Int. J. Obesity, 15, 809
- Buchberger, 1996, Am. J. Physiol., 271, R472
Cited by
Items 301–400 of 829
Metabolic Stress and Disorders Related to Alterations in Mitochondrial Fission or Fusion.
Babbar, M., & Sheikh, M. S. (2013) · PubMed · Cited by 80
Energy imbalance alters Ca2+ handling and excitability of POMC neurons
Paeger, L., Pippow, A., Hess, S., Paehler, M., Klein, A. C., Husch, A., Pouzat, C., Brüning, J. C., & Kloppenburg, P. (2017) · eLife · doi:10.7554/elife.25641 · Cited by 63
“The starting point for this study was recent work that reported POMC neuron-specific altera- tions in mitochondrial morphology and decreased mitochondria-ER contacts in DIO by downregula- tion of MNF2 expression (Schneeberger et al., 2013).”
ResultEndosymbiosis and the design of eukaryotic electron transport
Berry, S. (2003) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(03)00084-7 · Cited by 73
Huang, Y., Chen, K., Ren, Q., Yi, L., Zhu, J., Zhang, Q., & Mi, M. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000493040 · Cited by 64
Role of Mitofusin 2 in the Renal Stress Response
Gall, J. M., Wang, Z., Liesa, M., Molina, A. J. A., Havasi, A., Schwartz, J. H., Shirihai, O. S., Borkan, S. C., & Bonegio, R. G. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031074 · Cited by 63
“, neuronal, cardiac and pancreatic development) [11,13,44,45] and that dynamic mitochondrial fusion and fragmentation is necessary to maintain a healthy mitochondrial population with optimal aerobic ATP production capacity [2,3,4,11,46].”
BackgroundRizzo, F., Ronchi, D., Salani, S., Nizzardo, M., Fortunato, F., Bordoni, A., Stuppia, G., Bo, R. D., Piga, D., Fato, R., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw258 · Cited by 72
The lifecycle of skeletal muscle mitochondria in obesity
Pileggi, C. A., Parmar, G., & Harper, M. (2021) · Obesity Reviews · doi:10.1111/obr.13164 · Cited by 61
“focus on the context of the mitochondrial network and glucose control, as it is particularly abundant in skeletal muscle.(120) Mechanistic studies have demonstrated that repression of MFN2 in cells leads to decreased mitochondrial membrane potential, impaired cellular respiration, and perturbed glucose oxidation.”
Backgrounddel Campo, A., Parra, V., Vásquez-Trincado, C., Gutiérrez, T., Morales, P. E., López-Crisosto, C., Bravo-Sagua, R., Navarro-Marquez, M. F., Verdejo, H. E., Contreras-Ferrat, A., et al. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00146.2013 · Cited by 61
“(Drp1K38A), antisense sequence against Mfn2 (AsMfn2), and miRNA against Opa1 (miOpa1) and miRNA control (miControl) have been described previously (2).”
BackgroundLidell, M. E., Seifert, E. L., Westergren, R., Heglind, M., Gowing, A., Sukonina, V., Arani, Z., Itkonen, P., Wallin, S., Westberg, F., et al. (2011) · Diabetes · doi:10.2337/db10-0409 · Cited by 61
“This is interesting since inhibition of fission and/or activation of fusion is found to counteract many of the disease phenotypes related to insulin resistance and diabetes (1,14,32).”
BackgroundMitofusin 2 Inhibits Angiotensin II-Induced Myocardial Hypertrophy
Yu, H., Guo, Y., Mi, L., Wang, Y., Li, L., & Gao, W. D. (2010) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248410385683 · Cited by 61
“Mitofusin 2 (Mfn2) plays a key role in the maintenance of the mitochondrial network and normal function in mammalian cells.(7) Our previous studies have demonstrated that Mfn2 acts as an endogenous Ras inhibitor and regulates vascular proliferative processes.”
BackgroundPhenotypic spectrum of MFN2 mutations in the Spanish population
Casasnovas, C., Banchs, I., Cassereau, J., Guéguen, N., Chevrollier, A., Martínez‐Matos, J. A., Bonneau, D., & Volpini, V. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2009.072488 · Cited by 61
“Mitochondria are dynamic organelles that are highly motile, undergoing frequent fusion and fission. MFN2 is located in the outer mitochondrial membrane and regulates the mitochondrial network architecture by fusion of mitochondria.”
BackgroundInsulin Resistance in Human iPS Cells Reduces Mitochondrial Size and Function
Burkart, A. M., Tan, K., Warren, L., Iovino, S., Hughes, K. J., Kahn, C. R., & Patti, M.-E. (2016) · Scientific Reports · doi:10.1038/srep22788 · Cited by 60
Tsilingiris, D., Tzeravini, E., Koliaki, C. C., Dalamaga, Μ., & Kokkinos, A. D. (2021) · Current Obesity Reports · doi:10.1007/s13679-021-00434-0 · Cited by 63
“In support of this statement, subjects with obesity display reduced levels of Mfn2 in skeletal muscle compared to their lean counterparts, while the shift of the fusion–fission balance towards fission results in substantial decreases of glucose oxidation and oxygen consumption [51].”
BackgroundMitofusin 2-Deficiency Suppresses Cell Proliferation through Disturbance of Autophagy
Ding, Y., Gao, H., Zhao, L., Wang, X., & Zheng, M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0121328 · Cited by 59
“Given that Mfn2 defect contributes to metabolic defects associated with obesity, neuropathy, as well as cardiac dysfunction[23,37,38], it is understandable that Mfn2-deficiency leads to the inhibition of cell proliferation.”
BackgroundMitofusin-2 is a novel direct target of p53
Wang, W., Cheng, X., Lu, J., Wei, J., Fu, G., Zhu, F., Jia, C., Zhou, L., Xie, H., & Zheng, S. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.08.108 · Cited by 61
Identification of a Novel Modulator of Thyroid Hormone Receptor-Mediated Action
Baumgartner, B. G., Orpinell, M., Durán, J., Ribas, V., Burghardt, H. E., Bach, D., Villar, A. V., Paz, J. C., González, M., Camps, M., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001183 · Cited by 64
“PCR-Select cDNA Subtraction kit (Clontech) was used to select genes that are downregulated in diabetic muscle [45].”
MethodSelf-citationMitochondria and heart failure: new insights into an energetic problem.
Chen, L., & Knowlton, A. A. (2010) · PubMed · Cited by 71
Kim, S., Song, J., Erñst, P., Latimer, M. N., Ha, C., Goh, K. Y., Ma, W., Namakkal-Soorappan, R. N., Zhang, J., Liu, M., et al. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00617.2019 · Cited by 60
Li, Y., Berliocchi, L., Li, Z., & Rasmussen, L. J. (2023) · Aging Cell · doi:10.1111/acel.13942 · Cited by 74
Skeletal muscle mitochondrial network dynamics in metabolic disorders and aging
Fealy, C. E., Grevendonk, L., Hoeks, J., & Hesselink, M. K. C. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2021.07.013 · Cited by 61
Yang, T., Qu, X., Wang, X., Xu, D., Sheng, M., Lin, Y., Ke, M., Song, C., Xia, Q., Jiang, L., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000638 · Cited by 65
“[35] Our further studies revealed that MFN2 deficiency reduced autophagy gene LC3 and lysosome LAMP1 expression in PA/ OA-stimulated hepatocytes after co-culture with STING M-KO macrophages.”
Larsen, T. D., Sabey, K. H., Knutson, A. J., Gandy, T. C. T., Louwagie, E. J., Lauterboeck, L., Mdaki, K. S., & Baack, M. L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20123090 · Cited by 57
“Therefore, the 50 kDa band is likely a muscle specific marker of nonconventional fusion related functions including MFN2 to ER/SR communication, calcium homeostasis, network morphology, and mitophagy-induced apoptosis [56,57].”
BackgroundHyperglycemia alters mitochondrial respiration efficiency and mitophagy in human podocytes
Audzeyenka, I., Rachubik, P., Typiak, M. J., Kulesza, T., Topolewska, A., Rogacka, D., Angielski, S., Saleem, M. A., & Piwkowska, A. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112758 · Cited by 67
Intertwined Relationship of Mitochondrial Metabolism, Gut Microbiome and Exercise Potential
Imdad, S., Lim, W., Kim, J., & Kang, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052679 · Cited by 75
Mitochondrial dysfunction in metabolism and ageing: shared mechanisms and outcomes?
López‐Lluch, G., Hernández‐Camacho, J. D., Fernández‐Ayala, D. J. M., & Navas, P. (2018) · Biogerontology · doi:10.1007/s10522-018-9768-2 · Cited by 65
Mitochondria-associated ER membranes in glucose homeostasis and insulin resistance
Townsend, L. K., Brunetta, H. S., & Mori, M. A. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00271.2020 · Cited by 59
Characterization of the mitofusin 2 R94W mutation in a knock‐in mouse model
Strickland, A. V., Rebelo, A. P., Zhang, F., Price, J. H., Bolon, B. N., Silva, J. P., Wen, R., & Zuchner, S. L. (2014) · Journal of the Peripheral Nervous System · doi:10.1111/jns5.12066 · Cited by 55
“MFN2 is known to be involved in regulating cell metabolism (Bach et al., 2003; Pich et al., 2005) and autophagy, where it is ubiquitinated by Parkin (Gegg et al., 2010).”
BackgroundWhat comes first, misshape or dysfunction? The view from metabolic excess
Galloway, C. A., & Yoon, Y. (2012) · Journal of General Physiology · doi:10.1085/jgp.201210771 · Cited by 55
“Similar findings were reported with samples from both complex I and multi-complex–deficient patients (Benard et al., 2007).”
BackgroundResultPan, S., Sharma, P. K., Shah, S. D., & Deshpande, D. A. (2017) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00106.2017 · Cited by 55
“Altered mitochondrial dynamics is found in human diseases and aging (1, 3, 24, 36, 58, 61, 62).”
Qiu, C., Yu, F., Su, K., Zhao, Q., Zhang, L., Xu, C., Hu, W., Wang, Z., Zhao, L., Tian, Q., et al. (2020) · iScience · doi:10.1016/j.isci.2020.100847 · Cited by 68
Get the balance right: Mitofusins roles in health and disease
Santel, A. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.02.004 · Cited by 62
Kitaoka, Y., Ogasawara, R., Tamura, Y., Fujita, S., & Hatta, H. (2015) · Applied Physiology Nutrition and Metabolism · doi:10.1139/apnm-2015-0184 · Cited by 54
“Disorders of mitochondrial dynamics can 74 lead to reduced mitochondrial respiratory capacity (Bach et al. 2003; Chen et al. 2005; Parone et 75 al.”
BackgroundInfluentialTol, M. J., Ottenhoff, R., van Eijk, M., Zelcer, N., Aten, J., Houten, S. M., Geerts, D., van Roomen, C. P. A. A., Bierlaagh, M. C., Scheij, S. S., et al. (2016) · Diabetes · doi:10.2337/db16-0243 · Cited by 61
Adipose tissue gene expression profiles in ob/ob mice treated with leptin
Zhang, W., Della‐Fera, M. A., Hartzell, D. L., Hausman, D. B., & Baile, C. A. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.04.021 · Cited by 59
“Recently, Mfn2 gene expression and protein were reported to be repressed in skeletal muscle of obese rats and human subjects (Bach et al., 2003) and increased in positive correlation with enhanced glucose oxidation following surgery for reducing body weight (Mingrone et al.”
Bórquez, J. C., Díaz-Castro, F., La Fuente, F. P.-D., Espinoza, K., Figueroa, A. M., Martínez-Ruíz, I., Hernández, V., López-Soldado, I., Ventura, R., Domingo, J. C., et al. (2024) · Metabolism · doi:10.1016/j.metabol.2023.155765 · Cited by 54
Castillo, Í. M. P., Argilés, J. M. A., Rueda, R., Ramírez, M., & Pedrosa, J. M. L. (2025) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-025-09954-9 · Cited by 81
“Particularly, MFN2 is highly expressed in skeletal muscle, and its expression has been shown to decrease in obese rodents and human subjects with obesity, and T2DM [181, 192, 193].”
Lou, Y., Li, R., Liu, J., Zhang, Y., Zhang, X., Jin, B., Liu, Y., Wang, Z., Zhong, H., Wen, S., et al. (2015) · Medical Oncology · doi:10.1007/s12032-015-0515-0 · Cited by 57
McLaughlin, D., Zhao, Y., O’Neill, K. M., Edgar, K. S., Dunne, P. D., Kearney, A. M., Grieve, D., & McDermott, B. J. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13773 · Cited by 55
“In particular, enhancement of MMP2 in cardiomyocytes in response to DOX has been identi fi ed as redox-dependent (Spallarossa et al., 2006; Mukhopadhyay et al., 2009; Bartekova et al., 2015).”
BackgroundMutational analysis of action of mitochondrial fusion factor mitofusin-2
Honda, S., Aihara, T., Hontani, M., Okubo, K., & Hirose, S. (2005) · Journal of Cell Science · doi:10.1242/jcs.02449 · Cited by 53
“…membrane potential has been observed in a significant population of embryonic fibroblasts established from Mfn1- or Mfn2knockout mice (Chen et al., 2003), and in cultured cells in which Mfn2 was depleted using an adenovirus vector expressing Mfn2-specific antisense cDNA (Bach et al., 2003).”
BackgroundThe Role of Mitochondrial Dynamic Dysfunction in Age-Associated Type 2 Diabetes
Vezza, T., Díaz-Pozo, P., Canet, F., de Marañón, A. M., Abad-Jiménez, Z., García-Gargallo, C., Roldan, I., Solá, E., Bañuls, C., López‐Domènech, S., et al. (2022) · The World Journal of Men s Health · doi:10.5534/wjmh.210146 · Cited by 65
“In light of the above-mentioned evidence, MFN2 has been proposed as a main player in diabetic mitochondrial dysfunction and in the progression of insulin resistance [58,65].”
BackgroundPossible Role of Mitochondrial Remodelling on Cellular Triacylglycerol Accumulation
Kita, T., Nishida, H., Shibata, H., Niimi, S., Higuti, T., & Arakaki, N. (2009) · Journal of Biochemistry · doi:10.1093/jb/mvp124 · Cited by 52
Deheshi, S., Dabiri, B., Fan, S., Tsang, M., & Rintoul, G. L. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13090 · Cited by 52
“The morphological state of mitochondria has been linked to their energy production capacity (Bach et al. 2003; Olichon et al. 2003; Chen et al. 2005; Benard and Rossignol 2008), as well as cell health, and cell death mechanisms (Cheung et al.”
BackgroundAdiponectin is required for maintaining normal body temperature in a cold environment
Wei, Q., Lee, J. H., Wang, H., Bongmba, O. Y. N., Wu, C., Pradhan, G., Sun, Z., Chew, L. A., Bajaj, M., Chan, L., et al. (2017) · BMC Physiology · doi:10.1186/s12899-017-0034-7 · Cited by 51
“Several studies show abnormal mitochondrial structure in obese and type 2 diabetic patients [57, 58].”
BackgroundNutrient availability links mitochondria, apoptosis, and obesity
Pintus, F., Floris, G., & Rufini, A. (2012) · Aging · doi:10.18632/aging.100505 · Cited by 51
“Repression of Mfn2 decreases oxygen consumption and mitochondrial membrane potential [14-16].”
BackgroundMitofusins: from mitochondria to fertility
Zhao, S., Heng, N., Wang, H., Wang, H., Zhang, H., Gong, J., Hu, Z., & Zhu, H. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04386-z · Cited by 55
“Apart from directly affecting the glucose metabolism pattern, Mfn2 might regulate the OXPHOS process by proton across, such as in muscle cell development, the repression of Mfn2 leads to reduced proton leakage [41].”
BackgroundCheng, X., Zhou, D., Wei, J., & Lin, J. (2013) · Neoplasma · doi:10.4149/neo_2013_080 · Cited by 51
Zhang, R., Zhou, H., Jiang, L., Mao, Y., Cui, X., Xie, B., Cui, D., Wang, H., Zhang, Q., & Xu, S. (2016) · Brain Research · doi:10.1016/j.brainres.2016.09.047 · Cited by 49
“Mfn2, a dynamin-related protein with GTPase activity, affects the mitochondrial structure and mediates the mitochondrial function by regulating mitochondrial fusion (Bach et al., 2003; Martorell-Riera et al., 2014).”
Insulin resistance syndrome blunts the mitochondrial anabolic response following resistance exercise
Nilsson, M. I., Greene, N. P., Dobson, J. P., Wiggs, M. P., Gasier, H. G., Macias, B. R., Shimkus, K. L., & Fluckey, J. D. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00118.2010 · Cited by 50
“Our findings, along with those of others (4, 32), show unequivocally that the obese phenotype exhibits a robust augmentation in mitochondrial protein concentrations (e.”
BackgroundResultThe role of mitochondrial fusion and fission in skeletal muscle function and dysfunction
Hood, D. A. (2015) · Frontiers in Bioscience · doi:10.2741/4303 · Cited by 50
“Moreover, the repression of Mfn2 has been shown to reduce glucose oxidation (7).”
BackgroundFunctional interplay of lipid droplets and mitochondria
Enkler, L., & Spang, A. (2024) · FEBS Letters · doi:10.1002/1873-3468.14809 · Cited by 63
“…associated with the metabolic status of the cell [16], cold stimulation in BAT [81,82], endurance exercise training [83], insulin-resistant conditions such as obesity or type 2 diabetes (T2D) [84,85], as well as bacterial infection [25,26], and are directed towards mitochondrial b -oxidation [86].”
BackgroundKruse, R., Pedersen, A. J. T., Kristensen, J. M., Petersson, S. J., Wojtaszewski, J. F. P., & Højlund, K. (2017) · Clinical Science · doi:10.1042/cs20160736 · Cited by 49
Maseroli, E., Comeglio, P., Corno, C., Cellai, I., Filippi, S., Mello, T., Galli, A., Rapizzi, E., Presenti, L., Truglia, M., et al. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01381-8 · Cited by 49
Role of Mitofusins and Mitophagy in Life or Death Decisions
Joaquim, M., & Escobar‐Henriques, M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.572182 · Cited by 52
Zhang, R., Han, M., Zheng, B., Li, Y., Shu, Y.-N., & Wen, J. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.96 · Cited by 48
Mitochondrial Dynamics and Liver Cancer
Hernández‐Álvarez, M. I., & Zorzano, A. (2021) · Cancers · doi:10.3390/cancers13112571 · Cited by 57
Self-citationFlores, E., Fernández-Novell, J. M., Peña, A., Rigau, T., & Rodríguez-Gil, J. E. (2010) · Theriogenology · doi:10.1016/j.theriogenology.2010.02.018 · Cited by 52
Obesity Affects Mitochondrial Citrate Synthase in Human Omental Adipose Tissue
Christe, M., Hirzel, E., Lindinger, A., Kern, B. E., von Flüe, M., Peterli, R., Peters, T. T. A., Eberlé, A. N., & Lindinger, P. W. (2013) · ISRN Obesity · doi:10.1155/2013/826027 · Cited by 55
“,MFN-2) [22] was shown to result in fragmented mitochondrial populations [23].”
BackgroundMolecular Genetics of Autosomal-Recessive Axonal Charcot-Marie-Tooth Neuropathies
Bernard, R., Sandre‐Giovannoli, A. D., Delague, V., & Lévy, N. (2006) · NeuroMolecular Medicine · doi:10.1385/nmm:8:1-2:87 · Cited by 49
“MFN2 is necessary for mitochondrial fusion and its proper transport along the cytoskeleton (Bach et al., 2003; Züchner et al., 2004b).”
BackgroundUrschel, M. R., & O’Brien, K. M. (2008) · Journal of Experimental Biology · doi:10.1242/jeb.018598 · Cited by 58
“For example, oxidative phosphorylation, apoptosis and proton leakage are all affected by mitochondrial architecture (Bach et al., 2003; Brand et al., 1994; Brooks et al., 2007; Mannella, 2006).”
BackgroundHolloway, G. P., Perry, C. G. R., Thrush, A. B., Heigenhauser, G. J. F., Dyck, D. J., Bonen, A., & Spriet, L. L. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00726.2007 · Cited by 48
“(4) reported that MFN-2 protein is significantly reduced ( 40%) with obesity, which is more difficult to explain.”
BackgroundInfluentialNie, Q., Wang, C., Song, G., Ma, H., Kong, D., Zhang, X., Gan, K., & Tang, Y. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3584-9 · Cited by 47
Role of oxidative stress in the process of vascular remodeling following coronary revascularization
Gallo, G., Pierelli, G., Forte, M., Coluccia, R., Volpe, M., & Rubattu, S. D. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.05.046 · Cited by 51
Hernández-Alvarez, M. I., Paz, J. C., Sebastián, D., Muñoz, J. P., Liesa, M., Segalés, J., Palacín, M., & Zorzano, A. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4269 · Cited by 46
“Next, we analyzed whether the effects of dexamethasone could be mimicked by the loss of function of Mfn2, a manipulation that causes mitochondrial fragmentation and which reduces glucose oxidation and mitochondrial respiration (3, 29).”
Self-citationMa, C., Zhang, C., Ma, M., Zhang, L., Zhang, L., Zhang, F., Chen, Y., Cao, F., Li, M., Wang, G., et al. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1541-5 · Cited by 48
Mitochondrial dynamics and metabolic homeostasis
Sebastián, D., & Zorzano, A. (2018) · Current Opinion in Physiology · doi:10.1016/j.cophys.2018.02.006 · Cited by 51
Self-citationInterorganellar calcium signaling in the regulation of cell metabolism: A cancer perspective
Rimessi, A., Pedriali, G., Vezzani, B., Tarocco, A., Marchi, S., Wieckowski, M. R., Giorgi, C., & Pinton, P. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.015 · Cited by 51
Nag, S., Szederkenyi, K., Gorbenko, O., Tyrrell, H., Yip, C. M., & McQuibban, G. A. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112895 · Cited by 53
Pawlikowska, P., Gajkowska, B., Hocquette, J.-F. J.-F., & Orzechowski, A. (2006) · Cell Proliferation · doi:10.1111/j.1365-2184.2006.00376.x · Cited by 48
“Mitochondria are intracellular organelles featured by a complex spatial organization with a network architecture determined by mitofusin proteins (Bach et al. 2003).”
BackgroundBalance is the challenge – The impact of mitochondrial dynamics in Parkinson’s disease
Burbulla, L. F., Krebiehl, G., & Krüger, R. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02354.x · Cited by 50
Li, J., Ke, W., Zhou, Q., Wu, Y., Luo, H., Zhou, H., Yang, B., Guo, Y. M., Zheng, Q., & Zhang, Y. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12320 · Cited by 45
“Loss or down-regulation of Mfn2 expression has been found in energy dysmetabolism-related diseases, such as obesity and diabetes [33, 34].”
BackgroundDahlmans, D., Houzelle, A., Schrauwen, P., & Hoeks, J. (2016) · Clinical Science · doi:10.1042/cs20150780 · Cited by 44
“In line with the findings in cell and animal models, nor-moglycaemic obese human subjects also displayed reduced protein levels of Mfn-2 in skeletal muscle, which were shown to be negatively correlated with BMI [22].”
ResultBhansali, S., Bhansali, A., & Dhawan, V. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14141 · Cited by 44
Shu, D. Y., Butcher, E. R., & Saint‐Geniez, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094701 · Cited by 50
“Indeed, TGFβ2 reduced both metabolic function (reduced maximal respiration and spare respiratory capacity) and expression of NDUFB5, a critical component of Complex I of the ETC known to play a role in maintaining the mitochondrial network architecture [26].”
BackgroundZheng, P., Ma, W., Gu, Y., Wu, H., Bian, Z., Liu, N., Yang, D., & Chen, X. (2023) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.22-73 · Cited by 51
Mitochondria: At the crossroads between mechanobiology and cell metabolism
Su, É., Villard, C., & Manneville, J. (2023) · Biology of the Cell · doi:10.1111/boc.202300010 · Cited by 47
Importance of Mitochondrial Dynamin-Related Protein 1 in Hypothalamic Glucose Sensitivity in Rats
Carneiro, L., Allard, C., Guissard, C., Fioramonti, X., Tourrel‐Cuzin, C., Bailbé, D., Barreau, C., Offer, G., Nédélec, E., Salin, B., et al. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4254 · Cited by 52
“These explanations are consistent with previous observations describing decreased glucose oxidation associated with mitochondrial dynamics disruption in peripheral tissues of obese patients (3, 4).”
Kitaoka, Y., Nakazato, K., & Ogasawara, R. (2016) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00465.2016 · Cited by 44
“We believe that these changes may contribute to improved mitochondrial function because dysfunctional, fragmented mitochondria have been observed in skeletal muscle obtained from individuals with obesity and type 2 diabetes, conditions associated with decreased levels of mitochondrial fusion proteins (1, 22).”
BackgroundWu, M., Chou, H., & Huang, C. (2014) · Marine Drugs · doi:10.3390/md12020964 · Cited by 43
“Mitochondria dysfunction is linked to obesity [3] and type 2 diabetes [4,5].”
BackgroundGender difference of androgen actions on skeletal muscle transcriptome
Yoshioka, M., Boivin, A., Bolduc, C., & St‐Amand, J. (2007) · Journal of Molecular Endocrinology · doi:10.1677/jme-07-0027 · Cited by 43
“Mfn2 has been reported to increase glucose oxidation, mitochondrial membrane potential, and cell respiration (Bach et al. 2003).”
BackgroundLuo, N., Yue, F., Jia, Z., Chen, J., Deng, Q., Zhao, Y., & Kuang, S. (2021) · The FASEB Journal · doi:10.1096/fj.202002464r · Cited by 53
Cellular Bioenergetics: Experimental Evidence for Alcohol-induced Adaptations
Simon, L., & Molina, P. E. (2022) · Function · doi:10.1093/function/zqac039 · Cited by 48
Wang, Y., Wu, L., Li, J., Fang, D., Zhong, C., Chen, J. X., & Yan, S. S. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-140972 · Cited by 42
“For example, elevated oxidative stress and impaired mitochondrial respiratory enzyme activity is often seen in diabetes in a variety of cell types including islet cells [31], hepatocytes [32], skeletal muscle cells [33, 34], blood mononuclear cells [35], endothelial cells [36], and dorsal root ganglion neurons [37, 38…”
Guillet, V., Guéguen, N., Cartoni, R., Chevrollier, A., Desquiret‐Dumas, V., Angebault, C., Amati‐Bonneau, P., Procaccio, V., Bonneau, D., Martinou, J., et al. (2011) · The FASEB Journal · doi:10.1096/fj.10-173609 · Cited by 51
“Metabolic explorations of cell models carrying MFN2 mutations responsible for CMT2A disease argue in favor of an energetic defect participating in the pathogenesis of the disorder (10, 12, 13).”
BackgroundMitofusin 2 Deficiency Affects Energy Metabolism and Mitochondrial Biogenesis in MEF Cells
Kawalec, M., Boratyńska-Jasińska, A., Beresewicz, M., Dymkowska, D., Zabłocki, K., & Zabłocka, B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134162 · Cited by 47
“It locates mainly in the outer mitochondrial membrane, and is involved in its rearrangement [1].”
BackgroundGesing, A., Masternak, M. M., Wang, F., Joseph, A.-M., Leeuwenburgh, C., Westbrook, R., Lewiñski, A., Karbownik‐Lewińska, M., & Bartke, A. (2011) · The Journals of Gerontology Series A · doi:10.1093/gerona/glr080 · Cited by 41
“Another important process involved in the regulation of mitochondrial activity and biogenesis is mitochondrial fusion and maintenance of the mitochondrial network architecture (31,32).”
BackgroundInfluentialCystathionine β‐synthase regulates mitochondrial morphogenesis in ovarian cancer
Chakraborty, P. K., Murphy, B., Mustafi, S. B., Dey, A., Xiong, X., Rao, G., Naz, S., Zhang, M., Yang, D., Dhanasekaran, D. N., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201701095r · Cited by 42
“Furthermore, the mRNA expression levels of MFN1 and MFN2 vary among tissues; MFN1 is highly expressed in the pancreas, heart, liver, adrenal glands, and testis (15, 16), whereas MFN2 is overexpressed in the skeletal muscle, brain, and brown adipose tissue (15, 17).”
BackgroundZhang, J., Wang, M., Wang, R., Sun, X., Du, Y., Ye, J., Sun, G., & Sun, X. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00487 · Cited by 45
“Its fusion and cleavage properties ensure the correctness of mitochondrial network structure for mitochondrial biogenesis (Bach et al., 2003; Garnier et al., 2005).”
BackgroundMitochondrial dynamic modulation exerts cardiometabolic protection in obese insulin-resistant rats
Maneechote, C., Palee, S., Apaijai, N., Kerdphoo, S., Jaiwongkam, T., Chattipakorn, S. C., & Chattipakorn, N. (2019) · Clinical Science · doi:10.1042/cs20190960 · Cited by 41
Mitochondrial Bioenergetics and Dynamics in Secretion Processes
Martínez, J., Marmisolle, I., Tarallo, D., & Quijano, C. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00319 · Cited by 46
Proteins That Fuse and Fragment Mitochondria in Apoptosis: Con-Fissing a Deadly Con-Fusion?
Scorrano, L. (2005) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-005-6572-x · Cited by 50
Holness, M. J., Caton, P., & Sugden, M. C. (2010) · Nutrition · doi:10.1016/j.nut.2009.09.012 · Cited by 45
“Mfn2 has been identified in rat skeletal muscle and Mfn2 repression has been detected in skeletal muscle of obese Zucker rats [65], which lack functional leptin receptors and have an altered skeletal muscle metabolism characterized by reduced glucose oxidation and oxygen consumption, insulin resistance, and reduced ex…”
BackgroundThaher, O., Wolf, C., Dey, P. N., Pouya, A., Wüllner, V., Tenzer, S., & Methner, A. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.05.009 · Cited by 41
“Others however found reduced mitochondrial membrane potential, cellular respiration and leak in myoblasts after downregulation by antisense oligonucleotides (Bach et al., 2003).”
BackgroundHypothalamic Mitochondrial Dysfunction as a Target in Obesity and Metabolic Disease
Cuñarro, J., Casado, S., Lugilde, J., & Tovar, S. A. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00283 · Cited by 43
“The protein or mRNA expression of Mfn1 and Mfn2 is variable among different tissues; Mfn1 is preferentially expressed in heart, liver, pancreas, adrenal glands, and testis (42, 43), whereas Mfn2 is more abundant in heart, skeletal muscle, brain, adrenal glands, and brown adipose tissue (4, 42, 44).”
BackgroundMFN2 Plays a Distinct Role from MFN1 in Regulating Spermatogonial Differentiation
Chen, W., Sun, Y. W., Sun, Q., Zhang, J., Jiang, M., Chang, C.-W., Huang, X., Wang, C., Wang, P., Zhang, Z., et al. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.03.024 · Cited by 44
“Notably, MFN2 mutations have been identified from patients with metabolic alterations (Bach et al., 2003; Rovira-Llopis et al., 2017).”
BackgroundMitochondrial biogenesis: a potential therapeutic target for osteoarthritis
Blanco, F. J., & Fernández-Moreno, M. (2020) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2020.03.018 · Cited by 42
Honda, S., & Hirose, S. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.10.008 · Cited by 45
Mitofusin 2 (Mfn2): a key player in insulin-dependent myogenesis in vitro
Pawlikowska, P., Gajkowska, B., & Orzechowski, A. (2006) · Cell and Tissue Research · doi:10.1007/s00441-006-0320-3 · Cited by 42
“Consequently, the repression of Mfn2 in myotubes causes a reduction in glucose oxidation (Bach et al. 2003).”
BackgroundResultJheng, H., Huang, S., Kuo, H., Hughes, M. W., & Tsai, Y. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12863 · Cited by 39
Antioxidant and anti-inflammatory effects of exercise: role of redox signaling
Ji, L. L., & Zhang, Y. (2014) · Free Radical Research · doi:10.3109/10715762.2013.844341 · Cited by 39
Zawada, I., Masternak, M. M., List, E. O., Stout, M. B., Berryman, D. E., Lewinski, A., Kopchick, J. J., Bartke, A., Karbownik-Lewinska, M., & Gesing, A. (2015) · Aging · doi:10.18632/aging.100733 · Cited by 39
“MFN2 plays an essential role in mitochondrial fusion and maintenance of the mitochondrial network architecture [7, 8], which is essential for mitochondrial activity and biogenesis.”
Background
Metadata
- Authors
- Bach, D., Pich, S., Soriano, F. X., Vega, N., Baumgartner, B., Oriola, J., Daugaard, J. R., Lloberas, J., Camps, M., Zierath, J. R., Rabasa-Lhoret, R., Wallberg-Henriksson, H., Laville, M., Palacı́n, M., Vidal, H., Rivera, F., Brand, M., & Zorzano, A.
- Affiliations
- Parc Científic de Barcelona (ES)
- Hospital Clínic de Barcelona (ES)
- Universitat de Barcelona (ES)
- Karolinska University Hospital (SE)
- Inserm (FR)
- MRC Mitochondrial Biology Unit (GB)
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-05
- Volume
- 278
- Issue
- 19
- Pages
- 17190-17197
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2127806759
- Cited by
- 832
- References
- 50
- Citations by year
- 2026: 16 · 2025: 22 · 2024: 28 · 2023: 49 · 2022: 32 · 2021: 40 · 2020: 63 · 2019: 45 · 2018: 52 · 2017: 45 · 2016: 48 · 2015: 32 · 2014: 47 · 2013: 49 · 2012: 54
- FWCI
- 6.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6378 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- mitofusin 2, mitochondrial fusion, mitochondrial metabolism, myogenesis, muscle mitochondria, mitochondrial fragmentation, glucose oxidation, mitochondrial membrane potential, cellular respiration, mitochondrial proton leak, obesity, mitochondrial membrane proteins
- MeSH terms
- Animals, Gene Expression Regulation, Humans, Membrane Potentials, Membrane Proteins, Middle Aged, Mitochondria, Muscle, Obesity, Rats, Zucker, Muscle, Skeletal, GTP Phosphohydrolases, Mitochondrial Proteins, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-11-03, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-03 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.